Neuroone Medical Technologies (NMTC) EBITDA Margin (QoQ) (2011 - 2026)
Neuroone Medical Technologies (NMTC) EBITDA Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 587.00 |
| Mar 31, 2026 | -6,972.00 |
| Dec 31, 2025 | -900.00 |
| Sep 30, 2025 | 6,121.00 |
| Jun 30, 2025 | 8,205.00 |
| Mar 31, 2025 | -24,555.00 |
| Dec 31, 2024 | 108,675.00 |
| Sep 30, 2024 | -69,615.00 |
| Jun 30, 2024 | -12,879.00 |
| Mar 31, 2024 | 13,725.00 |
| Dec 31, 2023 | 7,984.00 |
| Sep 30, 2023 | 13,062.00 |
| Jun 30, 2023 | 19,265.00 |
| Mar 31, 2023 | 80,740.00 |
| Dec 31, 2022 | 47,821.00 |
| Sep 30, 2022 | 658,076.00 |
| Jun 30, 2022 | -25,249.00 |
| Mar 31, 2022 | -3,937.00 |
| Dec 31, 2021 | -285,412.00 |
| Sep 30, 2021 | 209,903.00 |